Learn more Pfizer and Innovent Biologics have signed a global licensing and collaboration agreement worth up to $10.5bn for the research and development of a portfolio of 12 early-stage cancer ...

Researchers have demonstrated a promising new approach to stopping pancreatic cancer before it starts, using experimental drugs to eliminate microscopic precancerous lesions in the pancreas.

The U.S. Food and Drug Administration on Friday proposed to reduce animal studies conducted to assess safety in the development of certain cancer medications, marking the agency’s latest effort to ...

The trial is part of a larger trend towards targeted chemotherapies, Santin says, many of which may come onto the market in the next few decades.

A cancer diagnosis changes how people measure time. This article explores how advances in oncology research, precision ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

Pfizer and China’s Innovent Biologics signed a global agreement worth up to $10.5 billion, including a $650 million upfront ...

Researchers analyzing nearly 500 feline tumors across five countries identified genetic mutations linked to cancers in humans ...